Efficacy of Capecitabine Plus Oxaliplatin Combination Chemotherapy for Advanced Pancreatic Cancer after Failure of First-Line Gemcitabine-Based Therapy

BACKGROUND/AIMS: Second-line chemotherapy in patients with advanced pancreatic ductal adenocarcinoma (PDAC) that progresses following gemcitabine-based treatment has not been established. This study aimed to investigate the efficacy and safety of second-line combination chemotherapy with capecitabin...

Descripción completa

Detalles Bibliográficos
Autores principales: Chung, Kwang Hyun, Ryu, Ji Kon, Son, Jun Hyuk, Lee, Jae Woo, Jang, Dong Kee, Lee, Sang Hyub, Kim, Yong-Tae
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Editorial Office of Gut and Liver 2017
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5347656/
https://www.ncbi.nlm.nih.gov/pubmed/27965478
http://dx.doi.org/10.5009/gnl16307

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5347656/
https://www.ncbi.nlm.nih.gov/pubmed/27965478
http://dx.doi.org/10.5009/gnl16307

Ejemplares similares